Prognostic significance of MCM2, Ki-67 and gelsolin in non-small cell lung cancer

Prognostic significance of MCM2, Ki-67 and gelsolin in non-small cell lung cancer

<p>Abstract</p> <p>Background</p> <p>Uncontrolled proliferation and increased motility are hallmarks of neoplastic cells, therefore markers of proliferation and motility may be valuable in assessing tumor progression and prognosis. MCM2 is a member of the minichromosome...

Full description

Bibliographic Details
Main Authors:	Huberman Joel, Alrawi Sadir J, Swede Helen, Asch Harold L, Moysich Kirsten B, Ramnath Nithya, Yang Jun, Geradts Joseph, Brooks John SJ, Tan Dongfeng
Format:	Article
Language:	English
Published:	BMC 2006-08-01
Series:	BMC Cancer
Online Access:	http://www.biomedcentral.com/1471-2407/6/203

Similar Items

MCM6 versus Ki-67 in diagnosis of luminal molecular subtypes of breast cancers
by: Dorsay Sadeghian, et al.
Published: (2022-02-01)

Evaluation of the Ki-67 and MCM3 Expression in Cytologic Smear of Oral Squamous Cell Carcinoma
by: Fahimeh Rezazadeh, et al.
Published: (2017-09-01)

MCM3 proliferative index is worthier over Ki-67 in the characterization of salivary gland tumors
by: Ritika Raja, et al.
Published: (2021-01-01)

Mcm2, Geminin, and KI67 define proliferative state and are prognostic markers in renal cell carcinoma.
by: Dudderidge, T, et al.
Published: (2005)

Irisin Association with Ki-67, MCM3 and MT-I/II in Squamous Cell Carcinomas of the Larynx
by: Agnieszka Pinkowska, et al.
Published: (2021-12-01)

MCM - 2 and Ki - 67 as proliferation markers in renal cell carcinoma: A quantitative and semi - quantitative analysis
by: Muhammad Zain Mehdi, et al.

MCM-2, Ki-67, and EGFR downregulated expression levels in advanced stage laryngeal squamous cell carcinoma
by: Sarocha Vivatvakin, et al.
Published: (2021-07-01)

Correlation of Ki-67 and MCM-2 proliferative marker expression with grade of histological malignancy (G) in ductal breast cancers.
by: Marzena Podhorska-Okolow, et al.
Published: (2010-11-01)

MCM2 Expression in Different Molecular Subtypes of Epithelial Breast Cancers and its Association with Clinicopathological Parameters and Ki-67 Expression
by: MEGHADIPA MANDAL, et al.
Published: (2021-10-01)

Comparison between immunohistochemical expression of Ki-67 and MCM-3 in major salivary gland epithelial tumors in children and adolescents. Preliminary study
by: Rafał Zieliński, et al.
Published: (2017-02-01)

Corrigendum: To Ki or Not to Ki: Re-Evaluating the Use and Potentials of Ki-67 for T Cell Analysis
by: Francesca Di Rosa, et al.
Published: (2021-09-01)

The intrinsically disorderly story of Ki-67
by: Lucy Remnant, et al.
Published: (2021-08-01)

Proliferative activity in human breast cancer: Ki-67 automated evaluation and the influence of different Ki-67 equivalent antibodies
by: Gasperetti F, et al.
Published: (2011-03-01)

The expression of Ki-67 marker in the hydatidiform mole
by: Ecaterina Carpenco, et al.
Published: (2022-12-01)

MCM2 - a promising marker for premalignant lesions of the lung: a cohort study
by: Beck Amy F, et al.
Published: (2001-06-01)

Independent Clinical Validation of the Automated Ki67 Scoring Guideline from the International Ki67 in Breast Cancer Working Group
by: Ceren Boyaci, et al.
Published: (2021-10-01)

Quantum dots-based quantitative and in situ multiple imaging on ki67 and cytokeratin to improve ki67 assessment in breast cancer.
by: Jing Ping Yuan, et al.
Published: (2015-01-01)

Ki-67 expression is superior to mitotic count and novel proliferation markers PHH3, MCM4 and mitosin as a prognostic factor in thick cutaneous melanoma
by: Bachmann Ingeborg M, et al.
Published: (2010-04-01)

Ki67 and p53 in gastrointestinal stromal tumors - GIST Ki67 and p53 em tumores estromais gastrointestinais - GIST
by: Lúcio Roberto de Oliveira das Neves, et al.
Published: (2009-06-01)

Roles of Ki67 in Breast Cancer - Important for Management?
by: Yip, C.H., et al.
Published: (2016)

KI-67 AS A PROGNOSTIC FACTOR OF MYELODYSPLASTIC SYNDROME
by: G.S. Starodub, et al.
Published: (2016-04-01)

The cell proliferation antigen Ki-67 organises heterochromatin
by: Michal Sobecki, et al.
Published: (2016-03-01)

Characterization and analysis of Ki-67-immunoreactivity in brain astrocytoma
by: Shpon‘ka I.S., et al.
Published: (2016-03-01)

The relationship between the expression of Ki-67 and the prognosis of osteosarcoma
by: Ming Zeng, et al.
Published: (2021-03-01)

KI67 AND P53 PROTEINS IN ODONTOGENIC KERATOCYST
by: S Seifi, et al.
Published: (2008-12-01)

Ki-67 expression in anal intraepithelial neoplasia in AIDS
by: Edenilson Eduardo Calore, et al.
Published: (2001-05-01)

Cutaneous Canine Mast Cell Tumor: The Use of Proliferative Markers (Ki-67 and Ki-67 × AgNOR) in Cytological Samples for Diagnosis and Prognosis
by: Christina Marouda, et al.
Published: (2024-01-01)

Assessment of Ki67 in Breast Cancer: A Comparison Between the Eye-10 Method, Stepwise Counting Strategy, and International System of Ki67 Evaluation
by: Maryam Kadivar, et al.
Published: (2020-01-01)

Gelsolin-Like Domain 3 Plays Vital Roles in Regulating the Activities of the Lily Villin/Gelsolin/Fragmin Superfamily.
by: Dong Qian, et al.
Published: (2015-01-01)

The pattern of Ki-67 and bcl-2 expression in Lymphoid Malignancies
by: Wang, P.L., et al.
Published: (1997)

Blood biomarkers and Ki-67 proliferation marker in breast cancer
by: A. A. Studenikina, et al.
Published: (2023-04-01)

Expression of P53 and Ki-67 in Different Grades of Astrocytomas
by: Rania Rifat Abdel-Maqsoud Mohamed, et al.
Published: (2022-07-01)

Exploring the Prognostic and Predictive Roles of Ki-67 in Endometrial Cancer
by: Laura Paleari, et al.
Published: (2023-11-01)

Utility of Serum Ki-67 as a Marker for Malignancy in Dogs
by: Annkathrin Estaller, et al.
Published: (2022-05-01)

Ki-67 as a Prognostic Biomarker in Invasive Breast Cancer
by: Matthew G. Davey, et al.
Published: (2021-09-01)

IMMUNOHISTOCHEMICAL ANALYSIS BY KI67 AND IDH1 IN PATIENTS WITH CHONDROSARCOMA
by: MARCELO BARBOSA RIBEIRO, et al.
Published: (2023-07-01)

Ki-67 protein: a proliferation index in breast cancer
by: Shervin Kheirandish, et al.
Published: (2015-10-01)

Relationship Between SUVmax and Ki-67 Expression in Breast Cancer
by: Meriç Emre Bostancı, et al.
Published: (2020-09-01)

Ki67 quantitative interpretation: Insights using image analysis
by: Zoya Volynskaya, et al.
Published: (2019-01-01)

Ki-67 evaluation in breast cancer: The daily diagnostic practice
by: Lukasz Fulawka, et al.
Published: (2017-01-01)